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In this issue Quarterman and associates1 address an issue that continues toplague thoracic surgeons. In patients with solitary pulmonary nodules, is itbest, as some authors advocate, to excise each and every one of them fordiagnosis or can one be selective in proposing excisional therapy to providea diagnosis? There are many diagnostic options when one encounters sucha patient. Imaging techniques, including review of previous radiographs,
might allow one to determine conclusively that the lesion in question is benign. For
those lesions larger than 1 cm, the use of positron emission tomographic scanning
or less invasive transthoracic or transbronchial biopsy techniques can be accurate in
up to 90% of cases so investigated.2 The question addressed by these authors is
whether watchful observation for a short time is a reasonable alternative, only
intervening if this observational period suggests that malignancy is still a possibility.
When one encounters a solitary pulmonary nodule in which previous imaging is
not available for comparison, it certainly is reasonable to repeat the imaging
procedure in 2 to 3 weeks to ensure that the lesion has not disappeared. Some
practitioners advocate a course of antibiotic therapy in conjunction with this.
With the increased use of screening spiral computed tomographic scans and the
availability of 3-dimensional (3-D) reconstruction, it is now possible to assess the
growth of a lesion within 1 month of identification. Although the size might not
increase significantly, the shape of the lesion might alter such that growth can be
implied.3 This is especially valuable in subcentimeter lesions in which minimally
invasive approaches to diagnosis might not be available. It is highly likely, consid-
ering tumor doubling time, that most lesions can be identified as potentially
malignant with as short a period of observation as 1 to 2 months.
What the authors try to address is, is it harmful to observe lesions for a more
extended period of time? Although they do recognize the limitations of their study,
their conclusions do suggest that observation for greater than 3 months might not
adversely affect cancer survival. Unfortunately, because of the limitations of this
study, I do not believe that their conclusions are necessarily valid. As a sideline, it
is interesting to note that of the delays greater than 6 months, only one could be
attributed to planned observation. However, this article does challenge us to study
this question in a more controlled prospective way.
The early reported results of spiral computed tomographic screening studies
suggest that in the very tiny (5 mm) lesions, for which many of the protocols
allowed 3-month observation, those patients ultimately given a diagnosis of lung
cancer fell mainly into the very early (T1 N0) stage and, at last report, have survived
their treatment without tumor recurrence. Too early intervention can be harmful by
increasing invasive diagnostic approaches.4
What can we conclude from the work of Quarterman and associates? When
presented with a patient with a pulmonary abnormality, attempts at early diagnosis
should be made whenever possible. However, when watchful observation appears to
be the diagnostic approach of choice, the clinician does have the option of a
short-term watchful waiting period (ie, the shorter, the better), despite no evidence
at the present that a longer waiting time has an adverse outcome effect.
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